Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment-Reference-Cited by-同舟云学术

Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment

Published:2016-07 Issue:1 Volume:70 Page:45-53
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Tomlins Scott A.,Day John R.,Lonigro Robert J.,Hovelson Daniel H.,Siddiqui Javed,Kunju L. Priya,Dunn Rodney L.,Meyer Sarah,Hodge Petrea,Groskopf Jack,Wei John T.,Chinnaiyan Arul M.

Publisher

Elsevier BV

Subject

Urology

Reference30 articles.

1. Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up;Andriole;J Natl Cancer Inst,2012

2. What do the screening trials really tell us and where do we go from here?;Etzioni;Urol Clin North Am,2014

3. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up;Schroder;Lancet,2014

4. Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial;Thompson;J Natl Cancer Inst,2006

5. Critical review of prostate cancer predictive tools;Shariat;Future Oncol,2009

Cited by 319 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From microscopes to molecules: The evolution of prostate cancer diagnostics;Cytojournal;2024-08-29

2. Integration of expression datasets to identify biomarkers for accurate Gleason scoring in Prostate Cancer;2024-08-22

3. Advances in multiparametric magnetic resonance imaging combined with biomarkers for the diagnosis of high-grade prostate cancer;Frontiers in Surgery;2024-07-16

4. Prostate cancer reshapes the secreted and extracellular vesicle urinary proteomes;Nature Communications;2024-06-13

5. Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer;JAMA Oncology;2024-06-01